PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model
✍ Scribed by Weihua Li; Gang Niu; Lixin Lang; Ning Guo; Ying Ma; Dale O. Kiesewetter; Joseph M. Backer; Baozhong Shen; Xiaoyuan Chen
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 949 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background The aim of this study was to determine prospectively the incremental value of positron emission tomography/computed tomography (PET/CT) over conventional assessment (clinical examination and CT/MRI imaging). ## Methods All patients undergoing ^18^F‐fluorodeoxyglucose (F
## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck
## Abstract ## Background. We investigated the accuracy of performing cervical nodal evaluation with using integrated ^18^F‐fluoro deoxyglucose positron emission tomography (PET)/CT for squamous cell carcinoma (SCC) of the head and neck as compared with using PET and contrast‐enhanced CT (CECT) al